Phase 1 Trial — Peptide Glossary | RetatrutideCompare
First-in-human study, typically in 20-80 healthy volunteers. Focuses on safety, tolerability, pharmacokinetics, and dose-finding rather than efficacy.
Category: Clinical & Regulatory
First-in-human study, typically in 20-80 healthy volunteers. Focuses on safety, tolerability, pharmacokinetics, and dose-finding rather than efficacy.
Category: Clinical & Regulatory